Abstract
Tissue non-specific alkaline phosphatase (TNAP) may be involved in the synthesis of GABA and adenosine, which are the main inhibitory neurotransmitters in cortex. We explored this putative TNAP function through electrophysiological recording (local field potential ) in slices of mouse somatosensory cortex maintained in vitro . We used tetramisole , a well documented TNAP inhibitor, to block TNAP activity. We expected that inhibiting TNAP with tetramisole would lead to an increase of neuronal response amplitude, owing to a diminished availability of GABA and/or adenosine. Instead, we found that tetramisole reduced neuronal response amplitude in a dose-dependent manner. Tetramisole also decreased axonal conduction velocity. Levamisole had identical effects. Several control experiments demonstrated that these actions of tetramisole were independent from this compound acting on TNAP. In particular, tetramisole effects were not stereo-specific and they were not mimicked by another inhibitor of TNAP, MLS-0038949 . The decrease of axonal conduction velocity and preliminary intracellular data suggest that tetramisole blocks voltage-dependent sodium channels . Our results imply that levamisole or tetramisole should not be used with the sole purpose of inhibiting TNAP in living excitable cells as it will also block all processes that are activity-dependent. Our data and a review of the literature indicate that tetramisole may have at least four different targets in the nervous system. We discuss these results with respect to the neurological side effects that were observed when levamisole and tetramisole were used for medical purposes, and that may recur nowadays due to the recent use of levamisole and tetramisole as cocaine adulterants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Note that GAD is one among multiple PLP-dependent enzymes. Approximately 60 genes encoding for enzymes using PLP as cofactor have been identified in mammals (Percudani and Peracchi 2009). In addition to GAD, some of these enzymes are directly involved in the synthesis of other neurotransmitters such as dopamine and serotonin (Ermonval et al. 2009).
- 2.
Orthodromic responses could not be tested with 2 mM tetramisole: among the 4 experiments in which we used this concentration, 2 showed no measurable orthodromic response in the control condition, while in the other 2 experiments the orthodromic response obtained in the control condition failed to recover.
- 3.
Adverse reactions after single levamisole or tetramisole doses have been consistently reported in veterinary medicine, and were usually attributed to their actions on ganglionic ACh receptors (reviewed in Hsu 1980).
- 4.
In the context of cancer therapy, levamisole has also been reported to possess antiproliferative action in vitro (Kovach et al. 1992; Artwohl et al. 2000). However, the levamisole concentrations required to achieve significant effects in vitro appear to be much higher than the plasmatic concentration of levamisole in clinical therapy. Levamisole concentration in a range similar to the plasmatic concentration measured in patients fails to prevent the proliferation of cancer cell lines in vitro (Grem and Allegra 1989; Wiebke et al. 2003).
- 5.
The epileptic seizures that have been observed in the course of chronic levamisole treatments have all been reported in children but not in adults. This offers another interesting parallel with vitamin B6 metabolism alteration: experimental studies showed that vitamin B6 deficiency results in epileptic crisis in young animals but not in the adults (Daniel et al. 1942; Guilarte 1989).
- 6.
In addition to its involvement as an ectonucleotidase, TNAP could also intervene in myelination through vitamin B6 metabolism. In support for a role of PLP in myelination, it has been reported that vitamin B6 deficiency during development results in altered myelination (Lott et al. 1978; Kirksey et al. 1990). Indeed, PLP is a cofactor for two enzymes (serine palmitoyltransferase and sphingosine-1-phosphatelyase) involved in sphingolipid synthesis (Bourquin et al. 2011). Among sphingolipids, sphingomyelin, as expected from its name, happens to be particularly abundant in myelin. On the other hand, if myelination impairments observed in levamisole-induced multifocal leukoencephalopathy were consecutive to altered vitamin B6 metabolism, another PLP-dependent process, GABA synthesis, should also be impaired. This should result in occurrences of epileptic seizures in patients with levamisole-induced leukoencephalopathy, which, to our knowledge, have not been reported in case studies.
- 7.
In France for example, levamisole can still be used for the treatment of pediatric nephrotic syndrome, but under very restrictive conditions.
References
Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32:19–29
Aceves J, Erlij D, Martínez-Marañón R (1970) The mechanism of the paralysing action of tetramisole on Ascaris somatic muscle. Br J Pharmacol 38:602–607
Ahmed FY, Leonard GA, A’Hern R, Taylor AE, Lorentzos A, Atkinson H, Moore J, Nicolson MC, Riches PG, Gore ME (1996) A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma. Br J Cancer 74:1109–1113
Anagnostou F, Plas C, Forest N (1996) Ecto-alkaline phosphatase considered as levamisole-sensitive phosphohydrolase at physiological pH range during mineralization in cultured fetal calvaria cells. J Cell Biochem 60:484–494
Arnaud JP, Buyse M, Nordlinger B, Martin F, Pector JC, Zeitoun P, Adloff A, Duez N (1989) Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg 76:284–289
Artwohl M, Hölzenbein T, Wagner L, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer SM (2000) Levamisole induced apoptosis in cultured vascular endothelial cells. Br J Pharmacol 131:1577–1583
Atchison WD, Geary TG, Manning B, VandeWaa EA, Thompson DP (1992) Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle. Toxicol Appl Pharmacol 112:133–143
Aymard JP, Janot C, Thibaut G, Bertrand F, Legras B, Lederlin P, Streiff F (1984) Levamisole in chronic lymphocytic leukaemia: a prospective study of 15 patients. Acta Haematol 71:316–321
Balasubramaniam S, Bowling F, Carpenter K, Earl J, Chaitow J, Pitt J, Mornet E, Sillence D, Ellaway C (2010) Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5′-phosphate availability. J Inherit Metab Dis Suppl 3:S25–S33
Barth A, Morton DL (1995) The role of adjuvant therapy in melanoma management. Cancer 75(S2):726–734
Bartos M, Rayes D, Bouzat C (2006) Molecular determinants of pyrantel selectivity in nicotinic receptors. Mol Pharmacol 70:1307–1318
Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Bürgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Högler W (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T > C, p. M226T; c.1112C > T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40:1655–1661
Béthenod M, Cotte MF, Collombel C, Fréderich A, Cotte J (1967) Hypophosphatasie à révélation néo-natale. Amélioration osseuse. Encéphalopathie convulsivante fatale. Ann Pediatr (Paris) 14:835–841
Blanc PD, Chin C, Lynch KL (2012) Multifocal inflammatory leukoencephalopathy associated with cocaine abuse: is levamisole responsible? Clin Toxicol 50:534–535
Boison D (2012) Adenosine dysfunction in epilepsy. Glia 60:1234–1243
Borgers M (1973) The cytochemical application of new potent inhibitors of alkaline phosphatases. J Histochem Cytochem 21:812–824
Bostock H, Sears TA, Sherratt RM (1981) The effects of 4-aminopyryridine and tetraethylamonium ions on normal and demyelinated mammalian nerve fibres. J Physiol 313:301–315
Bourne G (1943) The distribution of alkaline phosphatase in various tissues. Quart J exp physiol 32:1–20
Bourquin F, Capitani G, Grütter MG (2011) PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. Protein Sci 20:1492–1508
Bozik ME, Gilbert MR (1994) The role of levamisole in 5-fluorouracil-levamisole-associated multifocal leukoencephalopathy. Ann Neurol 36:295
British Association for Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337: 1555–1557
Brugmans J, Schuermans V, De Cock W, Thienpont D, Janssen P, Verhaegen H, Van Nimmen L, Louwagie AC, Stevens E (1973) Restoration of host defense mechanisms in man by levamisole. Life Sci 13:1499–1504
Brumberg JC, Nowak LG, McCormick DA (2000) Ionic mechanisms underlying repetitive high-frequency burst firing in supragranular cortical neurons. J Neurosci 20:4829–4843
Brun-Heath I, Ermonval M, Chabrol E, Xiao J, Palkovits M, Lyck R, Miller F, Couraud PO, Mornet E, Fonta C (2011) Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues. Cell Tissue Res 343:521–536
Buchanan JA, Lavonas EJ (2012) Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol 19:27–31
Bullock MW, Hand JJ, Waletzky E (1968) Resolution and racemization of dl-tetramisole, dl-6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole. J Med Chem 11:169–171
Butt AM (2011) ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin Cell Dev Biol 22:205–213
Calhau C, Martel F, Hipólito-Reis C, Azevedo I (2000) Differences between duodenal and jejunal rat alkaline phosphatase. Clin Biochem 33:571–577
Carter BC, Bean BP (2009) Sodium entry during action potentials of mammalian neurons: incomplete inactivation and reduced metabolic efficiency in fast-spiking neurons. Neuron 64:898–909
Casale JF, Colley VL, Legatt DF (2012) Determination of phenyltetrahydroimidazothiazole enantiomers (Levamisole/Dexamisole) in illicit cocaine seizures and in the urine of cocaine abusers via chiral capillary gas chromatography-flame-ionization detection: clinical and forensic perspectives. J Anal Toxicol 36:130–135
Chang TW, Fiumara N (1978) Treatment with levamisole of recurrent herpes genitalis. Antimicrob Agents Chemother 13:809–812
Chen TC, Hinton DR, Leichman L, Atkinson RD, Apuzzo ML, Couldwell WT (1994) Multifocal inflammatory leukoencephalopathy associated with levamisole and 5-fluorouracil: case report. Neurosurgery 35:1138–1142
Chlebowski RTL, Lillington L, Nystrom JS, Sayre J (1994) Late mortality and levamisole adjuvant therapy in colorectal cancer. Br J Cancer 69:1094–1097
Ciancaglini P, Yadav MC, Simão AM, Narisawa S, Pizauro JM, Farquharson C, Hoylaerts MF, Millán JL (2010) Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res 25:716–723
Cieślak M, Kukulski F, Komoszyński M (2011) Emerging role of extracellular nucleotides and adenosine in multiple sclerosis. Purinergic Signal 7:393–402
Cohen IS, Strichartz GR (1977) On the voltage-dependent action of tetrodotoxin. Biophys J 17:275–279
Collins GG, Anson J (1985) Adenosine A1 receptors mediate the inhibitory effects of exogenous adenosine in the rat olfactory cortex slice. Neuropharmacology 24:1077–1084
Connors BW, Malenka RC, Silva LR (1988) Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat. J Physiol 406:443–468
Cossart R, Bernard C, Ben-Ari Y (2005) Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci 28:108–115
Critchley P, Abbott R, Madden FJ (1994) Multifocal inflammatory leukoencephalopathy developing in a patient receiving 5-fluorouracil and levamisole. Clin Oncol (R Coll Radiol) 6:406
Dahl R, Sergienko EA, Su Y, Mostofi YS, Yang L, Simao AM, Narisawa S, Brown B, Mangravita-Novo A, Vicchiarelli M, Smith LH, O’Neill WC, Millán JL, Cosford ND (2009) Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J Med Chem 52:6919–6925
Daniel EP, Kline OD, Tolle CD (1942) A convulsive syndrome in young rats associated with pyridoxine deficiency. J Nutr 23:205–216
Dau PC, Johnson KP, Spitler LE (1976) The effect of levamisole on cellular immunity in multiple sclerosis. Clin Exp Immunol 26:302–309
de Bernard B, Bianco P, Bonucci E, Costantini M, Lunazzi GC, Martinuzzi P, Modricky C, Moro L, Panfili E, Pollesello P, Stagni N, Vittur F (1986) Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoprotein. J Cell Biol 103:1615–1623
De Col R, Messlinger K, Carr RW (2008) Conduction velocity is regulated by sodium channel inactivation in unmyelinated axons innervating the rat cranial meninges. J Physiol 586:1089–1103
Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M (2013) Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests. Bioorg Med Chem 21:7981–7987
Deisz RA, Prince DA (1989) Frequency-dependent depression of inhibition in guinea-pig neocortex in vitro by GABAB receptor feed-back on GABA release. J Physiol 412:513–541
Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C (1996) Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 93:9887–9892
Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32:79–87
Dinai Y, Pras M (1975) Levamisole in rheumatoid arthritis. Lancet 2(7934):556
Ermonval M, Baudry A, Baychelier F, Pradines E, Pietri M, Oda K, Schneider B, Mouillet-Richard S, Launay JM, Kellermann O (2009) The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells. PLoS ONE 4:e6497
Eyre P (1970) Some pharmacodynamic effects of the nematocides: methyridine, tetramisole and pyrantel. J Pharm Pharmacol 22:26–36
Fassas AB, Gattani AM, Morgello S (1994) Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest 12:379–383
Ferroir JP, Fenelon G, Beaugerie L, Avenin Recoing D (1994) Leucoencéphalopathie multifocale inflammatoire, complication de la chimiothérapie par 5 fluorouracil et levamisole. Rev Neurol (Paris) 150:471–474
Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7:423–436
Fields RD (2011) Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling. Semin Cell Dev Biol 22:214–219
Fleming JT, Squire MD, Barnes TM, Tornoe C, Matsuda K, Ahnn J, Fire A, Sulston JE, Barnard EA, Sattelle DB, Lewis JA (1997) Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits. J Neurosci 17:5843–5857
Fonta C, Imbert M (2002) Vascularization in the primate visual cortex during development. Cereb Cortex 12:199–211
Fonta C, Négyessy L, Renaud L, Barone P (2004) Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission. Cereb Cortex 14:595–609
Fonta C, Negyessy L, Renaud L, Barone P (2005) Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. J Comp Neurol 486:179–196
Fonta C, Négyessy L, Brun-Heath I, Ermonval M, Czege D, Nowak LG, Frances B, Xiao JS, Mornet E, Millán JL (2012) Bone TNAP in the brain: functions in neurotransmission. Bull Group Int Rech Sci Stomatol Odontol 51:27
Fonta C, Cruz T, Rosay B, Millán JL, Balayssac S, Gilard V, Malet-Martino M, Nowak LG (2014) A dual approach to explore the functions of the tissue nonspecific alkaline phosphatase (TNAP) in the brain. Ninth FENS Forum of Neuroscience, Milan, Italy. Abstract Number: FENS-1232
Fontanez DE, Porter JT (2006) Adenosine A1 receptors decrease thalamic excitation of inhibitory and excitatory neurons in the barrel cortex. Neuroscience 137:1177–1184
Fox DA, Ruan DY (1989) Time- and frequency-dependent effects of potassium channel blockers on large and medium diameter optic tract axons. Brain Res 498:229–242
Franz DN, Perry RS (1974) Mechanisms for differential block among single myelinated and non-myelinated axons by procaine. J Physiol 236:193–210
Fraser D (1957) Hypophosphatasia. Am J Med 22:730–746
Friede RL (1966) A quantitative mapping of alkaline phosphatase in the brain of the rhesus monkey. J Neurochem 13:197–203
Fucci N (2007) Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci Int 172:e1
Gilbert JW (2011) J Neuroimaging 21:e188
Goldstein DJ, Rogers CE, Harris H (1980) Expression of alkaline phosphatase loci in mammalian tissues. Proc Natl Acad Sci USA 77:2857–2860
González-Duarte A, Williams R (2013) Cocaine-induced recurrent leukoencephalopathy. Neuroradiol J 26:511–513
Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393–407
Grem JL, Allegra CJ (1989) Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells. J Natl Cancer Inst 81:1413–1417
Guilarte TR (1989) Regional changes in the concentrations of glutamate, glycine, taurine, and GABA in the vitamin B-6 deficient developing rat brain: association with neonatal seizures. Neurochem Res 14:889–897
Gulati OD, Hemavathi KG, Joshi DP (1985) Interactions of levamisole with some autonomic drugs on guinea-pig vas deferens. J Auton Pharmacol 5:19–23
Gwilt P, Tempero M, Kremer A, Connolly M, Ding C (2000) Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil. Cancer Chemother Pharmacol 45:247–251
Hadden JW, Lopez C, O’Reilly RJ, Hadden EM (1977) Levamisole and inosiplex: antiviral agents with immunopotentiating action. Ann NY Acad Sci 284:139–152
Hanics J, Barna J, Xiao J, Millán JL, Fonta C, Négyessy L (2012) Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain. Cell Tissue Res 349:459–471
Harrow ID, Gration KAF (1985) Mode of action of the anthelmintics morantel, pyrantel and levamisole on muscle cell membrane of the nematode Ascaris suum. Pestic Sci 16:662–672
Hershkowitz N, Ayala GF (1981) Effects of phenytoin on pyramidal neurons of the rat hippocampus. Brain Res 208:487–492
Hertz F, Deghenghi R (1985) Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats. Agents Actions 16:397–403
Hess C, Ritke N, Sydow K, Mehling LM, Ruehs H, Madea B, Musshoff F (2014) Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole. Drug Test Anal 6:1049–1054
Hodgkin AL, Katz B (1949) The effect of sodium ions on the electrical activity of giant axon of the squid. J Physiol 108:37–77
Hondeghem LM (1978) Validity of Vmax as a measure of the sodium current in cardiac and nervous tissues. Biophys J 23:147–152
Hook CC, Kimmel DW, Kvols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriguez M (1992) Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 3:262–267
Hoshi K, Amizuka N, Oda K, Ikehara Y, Ozawa H (1997) Immunolocalization of tissue non-specific alkaline phosphatase in mice. Histochem Cell Biol 107:183–191
Howe JR, Sutor B, Zieglgänsberger W (1987a) Characteristics of long-duration inhibitory postsynaptic potentials in rat neocortical neurons in vitro. Cell Mol Neurobiol 7:1–18
Howe JR, Sutor B, Zieglgänsberger W (1987b) Baclofen reduces postsynaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action. J Physiol 384:539–569
Hsu WH (1980) Toxicity and drug interactions of levamisole. J Am Vet Med Assoc 176:1166–1169
Ibusuki S, Katsuki H, Takasaki M (1998) The effects of extracellular pH with and without bicarbonate on intracellular procaine concentrations and anesthetic effects in crayfish giant axons. Anesthesiology 88:1549–1557
Irnich D, Tracey DJ, Polten J, Burgstahler R, Grafe P (2002) ATP stimulates peripheral axons in human, rat and mouse—differential involvement of A(2B) adenosine and P2X purinergic receptors. Neuroscience 110:123–129
Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD (2006) Astrocytes promote myelination in response to electrical impulses. Neuron 49:823–832
Israel ZH, Lossos A, Barak V, Soffer D, Siegal T (2000) Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole. Acta Oncol 39:117–120
Joly C, Palisse M, Ribbe D, De Calmes O, Genevey P (1998) Intoxication aiguë au levamisole “à dose de cheval”. La revue des SAMU 1998:237–240
Kao CY, Walker SE (1982) Active groups of saxitoxin and tetrodotoxin as deduced from actions of saxitoxin analogues on frog muscle and squid axon. J Physiol 323:619–637
Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527–532
Kimmel DW, Schutt AJ (1993) Multifocal leukoencephalopathy: occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc 68:363–365
Kimmel DW, Wijdicks EF, Rodriguez M (1995) Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology 45:374–376
Kirksey A, Morré DM, Wasynczuk AZ (1990) Neuronal development in vitamin B6 deficiency. Ann NY Acad Sci 585:202–218
Kouassi E, Caillé G, Léry L, Larivière L, Vézina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7:71–89
Kovach JS, Svingen PA, Schaid DJ (1992) Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase. J Natl Cancer Inst 84:515–519
Lahaie E (2012) Quel est le produit qui circule? In: Pousset M (ed) Observatoire Français des Drogues et des Toxicomanes; cocaïne, données essentielles, pp 35–41
Landow H, Kabat EA, Newman W (1942) Distribution of alkaline phosphatase in normal and in neoplastic tissues of the nervous system. A histochemical study. Arch Neurol Psychiatry 48:518–530
Langer D, Hammer K, Koszalka P, Schrader J, Robson S, Zimmermann H (2008) Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res 334:199–217
Larocque A, Hoffman RS (2012) Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol 50:231–241
Le Quesne PM, Goldberg V, Vajda F (1976) Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin. J Neurol Neurosurg Psychiatry 39:995–1000
Lee KC, Ladizinski B, Federman DG (2012) Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc 87:581–586
LeGatt DF (2009) New cocaine cutting agent poses greater risk to users. Clinical & Forensic Toxicology News, Sep 2009
Leichman L, Brown T, Poplin B (1993) Symptomatic, radiologic and pathologic changes in the central nervous system (CNS) associated with 5-fluorouracil (5-FU) and levamisole (LEV) therapy. Proc Am Soc Clin Oncol 12:198
Levandoski MM, Piket B, Chang J (2003) The anthelmintic levamisole is an allosteric modulator of human neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 471:9–20
Lewis JA, Wu CH, Levine JH, Berg H (1980) Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience 5:967–989
Liu HM, Hsieh WJ, Yang CC, Wu VC, Wu KD (2006) Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology 67:1065–1067
Lott IT, Coulombe T, Di Paolo RV, Richardson EP Jr, Levy HL (1978) Vitamin B6-dependent seizures: pathology and chemical findings in brain. Neurology 28:47–54
Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M (1997) 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler’s virus. Exp Neurol 147:123–129
Lucia P, Pocek M, Passacantando A, Sebastiani ML, De Martinis C (1996) Multifocal leucoencephalopathy induced by levamisole. Lancet 348:1450
Luyckx M, Cazin M, Brunet C, Cazin JC, Devulder B, Gosselin P, Adenis L, Cappelaere P, Granier AM, Demaille A (1983) Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects. Methods Find Exp Clin Pharmacol 5:467–469
Macdonald RL, Kang JQ, Gallagher MJ (2010) Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol 588:1861–1869
Macfarlane DG, Bacon PA (1978) Levamisole-induced vasculitis due to circulating immune complexes. Br Med J 1(6110):407–408
Marcus DJ, Swift TR, McDonald TF (1981) Acute effects of phenytoin on peripheral nerve function in the rat. Muscle Nerve 4:48–50
Martin DL, Rimvall K (1993) Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 60:395–407
Matute C, Torre I, Pérez-Cerdá F, Pérez-Samartín A, Alberdi E, Etxebarria E, Arranz AM, Ravid R, Rodríguez-Antigüedad A, Sánchez-Gómez M, Domercq M (2007) P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27:9525–9533
McCormick DA (1989) GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 62:1018–1027
Mehansho H, Henderson LM (1980) Transport and accumulation of pyridoxine and pyridoxal by erythrocytes. J Biol Chem 255:11901–11907
Millán JL (2006). Mammalian alkaline phosphatases. From biology to applications in medicine and biotechnology. Wiley-VCH Verlag GmbH & Co, Weinheim, Germany
Mitzdorf U (1985) Current source-density method and application in cat cerebral cortex: investigation of evoked potentials and EEG phenomena. Physiol Rev 65:37–100
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veerder MH, Mailliard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Int Med 122:321–326
Mohammad FK, Faris GA, Rhayma MS, Ahmed K (2006) Neurobehavioral effects of tetramisole in mice. Neurotoxicology 27:153–157
Mongeau JG, Robitaille PO, Roy F (1988) Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 2:398–401
Mori S, Nagano M (1985) Electron microscopic cytochemistry of alkaline phosphatase in neurons of rats. Arch Histol Jpn 48:389–397
Morley SR, Forrest ARW, Galloway JH (2006) Levamisole as a contaminant of illicit Cocaine. Int Assoc Forensic Toxicologists 44:6
Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40
Morris DC, Masuhara K, Takaoka K, Ono K, Anderson HC (1992) Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Miner 19:287–298
Murray CL, Ford WJ, Swenson KK, Heros D, Sperduto PW (1997) Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer. AJNR Am J Neuroradiol 18:1591–1592
Nandy K, Bourne GH (1963) Alkaline phosphatases in brain and spinal cord. Nature 200:1216–1217
Narisawa S, Fröhlander N, Millán JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432–446
Narisawa S, Wennberg C, Millán JL (2001) Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J Pathol 193:125–133
Négyessy L, Xiao J, Kántor O, Kovács GG, Palkovits M, Dóczi TP, Renaud L, Baksa G, Glasz T, Ashaber M, Barone P, Fonta C (2011) Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex. Neuroscience 172:406–418
Neu IS (1993) Multifocal inflammatory leukencephalopathy caused by adjuvant therapy with 5-fluorouracil and levamisole after resection for an adenocarcinoma of the colon. Acta Neurol Scand 87:70
Niaudet P, Drachman R, Gagnadoux MF, Broyer M (1984) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Paediatr Scand 73:637–641
Nowak LG, Bullier J (1996) Spread of stimulating current in the cortical grey matter of rat visual cortex studied on a new in vitro slice preparation. J Neurosci Methods 67:237–248
Ohkubo S, Kimura J, Matsuoka I (2000) Ecto-alkaline phosphatase in NG108-15 cells : a key enzyme mediating P1 antagonist-sensitive ATP response. Br J Pharmacol 131:1667–1672
Onuaguluchi G, Igbo IN (1987) Comparative local anaesthetic and antiarrhythmic actions of levamisole hydrochloride and lignocaine hydrochloride. Arch Int Pharmacodyn Ther 289:278–289
Pabst HF, Crawford J (1975) L-tetramisole. Enhancement of human lymphocyte response to antigen. Clin Exp Immunol 21:468–473
Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK (2006) Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches. Neurosci Res 56:14–20
Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8:263–264
Parkinson DR, Cano PO, Jerry LM, Capek A, Shibata HR, Mansell PW, Lewis MG, Marquis G (1977) Complications of cancer immunotherapy with levamisole. Lancet 1(8022):1129–1132
Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75–111
Percudani R, Peracchi A (2009) The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families. BMC Bioinformatics 10:273
Perry DC, Xiao Y, Nguyen HN, Musachio JL, Dávila-García MI, Kellar KJ (2002) Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82:468–481
Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC (2003) Ecto 5’-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468–13479
Pinner B, Davison JF, Campbell JB (1964) Alkaline Phosphatase in Peripheral Nerves. Science 145:936–938
Pinto V, Derkach VA, Safronov BV (2008) Role of TTX-sensitive and TTX-resistant sodium channels in Adelta- and C-fiber conduction and synaptic transmission. J Neurophysiol 99:617–628
Pires JG, Futuro-Neto HA, Oliveira AM, Cabral AM (1979) The effect of levamisole on the cardiac responses to sympathomimetics and on the amine uptake process. J Pharm Pharmacol 31:257–258
Prieur AM, Buriot D, Lefur JM, Griscelli C (1978) Possible toxicity of levamisole in children with rheumatoid arthritis. J Pediatr 93:304–305
Raeymaekers AH, Allewijn FT, Vandenberk J, Demoen PJ, Van Offenwert TT, Janssen PA (1966) Novel broad-spectrum anthelmintics. Tetramisole and related derivatives of 6-arylimidazo[2,1-b]thiazole. J Med Chem 9:545–551
Rathbun JC (1948) Hypophosphatasia; a new developmental anomaly. Am J Dis Child 75:822–831
Rayes D, De Rosa MJ, Bartos M, Bouzat C (2004) Molecular basis of the differential sensitivity of nematode and mammalian muscle to the anthelmintic agent levamisole. J Biol Chem 279:36372–36381
Raymond SA (1992) Subblocking concentrations of local anesthetics: effects on impulse generation and conduction in single myelinated sciatic nerve axons in frog. Anesth Analg 75:906–921
Rehni AK, Singh TG (2010) Levamisole-induced reduction in seizure threshold: a possible role of nicotinic acetylcholine receptor-mediated pathway. Naunyn Schmiedebergs Arch Pharmacol 382:279–285
Reid JM, Kovach JS, O’Connell MJ, Bagniewski PG, Moertel CG (1998) Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer. Cancer Chemother Pharmacol 41:477–484
Renoux G, Renoux M (1972) Antigenic competition and nonspecific immunity after a rickettsial infection in mice: restoration of antibacterial immunity by phenyl-imidothiazole treatment. J Immunol 109:761–765
Renoux G, Renoux M, Teller MN, McMahon S, Guillaumin JM (1976) Potentiation of T-cell mediated immunity by levamisole. Clin Exp Immunol 25:288–296
Rifkin DB, Compans RW, Reich E (1972) A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem 247:6432–64327
Robertson SJ, Martin RJ (1993) Levamisole-activated single-channel currents from muscle of the nematode parasite Ascaris suum. Br J Pharmacol 108:170–178
Ruuskanen O, Remes M, Mäkela AL, Isomäki H, Toivanen A (1976) Levamisole and agranulocytosis. Lancet 308:958–959
Sanchez MR (2000) Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine. Clin Dermatol 18:131–145
Sanchez-Vives MV, McCormick DA (2000) Cellular and network mechanisms of rhythmic recurrent activity in neocortex. Nat Neurosci 3:1027–1034
Savarese DM, Gordon J, Smith TW, Litofsky NS, Licho R, Ragland R, Recht L (1996) Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. The use of thallium SPECT imaging to assist in noninvasive diagnosis—a case report. Cancer 77:387–394
Scheinberg MA, Bezerra JB, Almeida FA, Silveira LA (1978) Cutaneous necrotising vasculitis induced by levamisole. Br Med J 1(6110):408
Schiller JH, Lindstrom M, Witt PL, Hank JA, Mahvi D, Wagner RJ, Sondel P, Borden EC (1991) Immunological effects of levamisole in vitro. J Immunother 10:297–306
Schneider S, Meys F (2011) Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005 to 2010. Forensic Sci Int 212:242–246
Schuermans Y (1975) Levamisole in rheumatoid arthritis. Lancet 1(7898):111
Schwarz SK, Puil E (1998) Analgesic and sedative concentrations of lignocaine shunt tonic and burst firing in thalamocortical neurones. Br J Pharmacol 124:1633–1642
Seidlin M, Straus SE (1984) Treatment of mucocutaneous herpes simplex infections. Clin Dermatol 2:100–116
Selzer ME (1979) The effect of phenytoin on the action potential of a vertebrate spinal neuron. Brain Res 171:511–521
Sergienko EA, Millán JL (2010) High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action. Nat Protoc 5:1431–1439
Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, Feinstein DL (2008) P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation 5:33
Shimizu N (1950) Histochemical studies on the phosphatase of the nervous system. J Comp Neurol 93:201–217
Simão AM, Bolean M, Hoylaerts MF, Millán JL, Ciancaglini P (2013) Effects of pH on the production of phosphate and pyrophosphate by matrix vesicles’ biomimetics. Calcif Tissue Int 93:222–232
Spector R (1978) Vitamin B6 transport in the central nervous system: in vivo studies. J Neurochem 30:881–887
Spector S, Munjal I, Schmidt DE (1998) Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain. Neuropsychopharmacology 19:417–427
Sperlágh B, Illes P (2014) P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 35:537–547
Spreafico F, Vecchi A, Mantovani A, Poggi A, Franchi G, Anaclerio A, Garattini S (1975) Characterization of the immunostimulants levamisole and tetramisole. Eur J Cancer 11:555–563
Stevens B, Porta S, Haak LL, Gallo V, Fields RD (2002) Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855–868
Street SE, Kramer NJ, Walsh PL, Taylor-Blake B, Yadav MC, King IF, Vihko P, Wightman RM, Millán JL, Zylka MJ (2013) Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci 33:11314–11322
Stys PK (2013) Pathoetiology of multiple sclerosis: are we barking up the wrong tree? F1000Prime Rep 5:20
Sugimura K, Mizutani A (1979) Histochemical and cytochemical studies of alkaline phosphatase activity in the synapses of rat brain. Histochemistry 61:123–129
Suzuki K, Yoshimura Y, Hisada Y, Matsumoto A (1994) Sensitivity of intestinal alkaline phosphatase to L-homoarginine and its regulation by subunit-subunit interaction. Jpn J Pharmacol 64:97–102
Symoens J, Veys E, Mielants M, Pinals R (1978) Adverse reactions to levamisole. Cancer Treat Rep 62:1721–1730
Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S (2014) Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child 99:211–215
Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490–493
Thienpont D, Vanparijs OF, Raeymaekers AH, Vandenberk J, Demoen JA, Allewijn FT, Marsboom RP, Niemegeers CJ, Schellekens KH, Janssen PA (1966) Tetramisole (R 8299), a new, potent broad spectrum anthelmintic. Nature 209:1084–1086
Toivanen A, Lassila O, Nordman E (1981) Lack of effect of levamisole on the immune function in melanoma patients. Cancer Immunol Immunother 10:191–195
Trautmann A (2009) Extracellular ATP in the immune system: more than just a “danger signal”. Sci Sig 2:pe6
Treurniet-Donker AD, Meischke-de Jongh ML, van Putten WL (1987) Levamisole as adjuvant immunotherapy in breast cancer. Cancer 59:1590–1593
Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24:1521–1529
van Belle H (1972) Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta 289:158–168
van Belle H (1976a) Kinetics and inhibition of rat and avian alkaline phosphatases. Gen Pharmacol 7:53–58
van Belle H (1976b) Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 22:972–976
van der Ham M, Albersen M, de Koning TJ, Visser G, Middendorp A, Bosma M, Verhoeven-Duif NM, de Sain-van der Velden MG (2012) Quantification of vitamin B6 vitamers in human cerebrospinal fluid by ultra performance liquid chromatography-tandem mass spectrometry. Anal Chim Acta 712:108–114
Vandevelde M, Boring JG, Hoff EJ, Gingerich DA (1978) The effect of levamisole on the canine central nervous system. J Neuropathol Exp Neurol 37:165–173
Vanhoutte PM, Van Nueten JM, Verbeuren TJ, Laduron PM (1977) Differential effects of the isomers of tetramisole on adrenergic neurotransmission in cutaneous veins of dog. J Pharmacol Exp Ther 200:127–140
Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45–51
Webster DJ, Whitehead RH, Richardson G, Hughes LE (1982) Levamisole: a double blind immunological study. Anticancer Res 2:29–32
Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann NY Acad Sci 1192:190–200
Whyte MP, Mahuren JD, Fedde KN, Cole FS, McCabe ER, Coburn SP (1988) Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5′-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest 81:1234–1239
Whyte MP, Mahuren JD, Vrabel LA, Coburn SP (1985) Markedly increased circulating pyridoxal-5′-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752–756
Wiebke EA, Grieshop NA, Loehrer PJ, Eckert GJ, Sidner RA (2003) Antitumor effects of 5-fluorouracil on human colon cancer cell lines: antagonism by levamisole. J Surg Res 111:63–69
Woestenborghs R, Michielsen L, Heykants J (1981) Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection. J Chromatogr 224:25–32
Wu VC, Huang JW, Lien HC, Hsieh ST, Liu HM, Yang CC, Lin YH, Hwang JJ, Wu KD (2006) Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine 85:203–213
Yao SQ, Li ZZ, Huang QY, Li F, Wang ZW, Augusto E, He JC, Wang XT, Chen JF, Zheng RY (2012) Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis. J Neurochem 123:100–112
Yokota T, Saito Y, Miyatake T (1994) Conduction slowing without conduction block of compound muscle and nerve action potentials due to sodium channel block. J Neurol Sci 124:220–224
Zakon HH (2012) Adaptive evolution of voltage-gated sodium channels: the first 800 million years. Proc Natl Acad Sci USA 109(Suppl 1):10619–10625
Zhang D, Xiong W, Chu S, Sun C, Albensi BC, Parkinson FE (2012) Inhibition of hippocampal synaptic activity by ATP, hypoxia or oxygen-glucose deprivation does not require CD73. PLoS ONE 7:e39772
Zimmermann H, Zebisch M, Sträter N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8:437–502
Acknowledgment
We would like to thank the SARA service and particularly Gregory Marsal for animal care. We acknowledge Pr José Luis Millán for his useful comments on this work while it was in progress. This work was supported by CNRS (PICS 4331), by Hypophosphatasie Europe (grant No. 88461) and by PHC Egide (Balaton 17341 UE).
Conflict of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nowak, L.G., Rosay, B., Czégé, D., Fonta, C. (2015). Tetramisole and Levamisole Suppress Neuronal Activity Independently from Their Inhibitory Action on Tissue Non-specific Alkaline Phosphatase in Mouse Cortex. In: Fonta, C., Négyessy, L. (eds) Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP). Subcellular Biochemistry, vol 76. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7197-9_12
Download citation
DOI: https://doi.org/10.1007/978-94-017-7197-9_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7196-2
Online ISBN: 978-94-017-7197-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)